Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BAHDI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-Trop2- (Q295-mcValCitPABC-A6)- (mcMMAF)
|
|||||
| Synonyms |
ADC389
Click to Show/Hide
|
|||||
| Organization |
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-7.5
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
a glycan-based conjugation extension of the GlycoDelete technology
|
|||||